Our Projects
Finalised Projects
Finalised Projects
Enhancing CAR-T cell therapy to treat childhood leukemia
WEHI (Walter and Eliza Hall Institute)
Enhancing CAR-T cell therapy to treat childhood leukemia
Novel targets for paediatric brain tumour immunotherapy
Exploiting and enhancing brain-resident immune cells for the treatment of paediatric brain stem glioma (DIPG)
An innovative approach to tackling treatment resistance in medulloblastoma by using bioinformatics and machine learning.
Associate Professor Melissa Davis, Joint Division Head, Bioinformatics: WEHI
Medulloblastoma is a devastating brain cancer that….
“Cage Fighting” Neuroblastoma
Dr Andrew Care: Macquarie University
Engineering a protein nanocage for targeted ionophoric-copper therapy
Hudson Monash Paediatric Precision Medicine (HMPPM) Program
Dilru Habarakad, is the Australian Lions Childhood Cancer Research Foundation (ALCCRF) Biobank Specialist for the Hudson Monash Paediatric Precision Medicine (HMPPM) Program.
Read about ALCCRF Achievements over 10 years
ALCCRF Clinical Research Fellow Dr Sara Khan
ALCCRF Fellowship is a 3 year $450,000 funding grant for:
Research project to investigate new therapeutic options for two of the most prevalent and aggressive paediatric brain tumours, Medulloblastoma and Diff use Intrinsic Pontine Glioma.
The Lions kids cancer Genome project
Trust Lions to be taking the next big step in kid’s cancer.
Every year in Australia, almost 800 kids are diagnosed with cancers, many of them aggressive, hard to treat and with a high risk of mortality.
Although the survival rates have improved greatly for some cancers, others still take a heavy toll on our young peoples’ lives. Lions have been helping these kids for the past 40 years.
But now, with the help of scientific breakthroughs in genetics, we are taking these efforts to a whole new level.
How we are going to help kids fight back against cancer.
The Australian Lions Cancer Research Foundation and Lions Club International Foundation (LCIF) have committed A$4 million to fund the whole genome sequencing of 400 children with high risk cancers in Australia over 3 years.
This funding will enable Garvan to work with the Children’s Cancer Institute to undertake
the sequencing, analysis and the creation of a database which can be used by researchers and doctors worldwide. It could help kids everywhere have a better chance of a healthy life.
It is also your chance to be part of a massive step forward in the fight against kids’ cancers.
The Lions Kids Cancer Genome Project (Genome Power) is a joint initiative of the Garvan Institute of Medical Research, the Lions Clubs International Foundation and the Australian Lions Childhood Cancer Research Foundation. Genome Power will be supporting Australia’s national personalised medicine program for childhood cancer – the Zero Childhood Cancer Program, led by Children’s Cancer Institute and the Kids Cancer Centre, Sydney Children’s Hospital, Randwick. In its first three years, Genome Power will provide whole genome sequencing and analysis for 400 children with high-risk cancer in Australia who will be enrolled in the Zero Childhood Cancer Program.
Read the Latest Report – May 2018 from Dr Joe Collins and Dr Marie Dziadek